Equifax, Inc. EFX

148.11 (0.69) (0.46%) as of 25 Sep
Market cap
$17.5B
P/E
25.8×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE 14.53% 14.61% 13.99% 13.33%

+8 more TTM periods

ROA 5.79% 5.87% 5.59% 5.45%
ROIC 8.68% 8.50% 8.05% 7.79%
Return on Tangible Assets 78.11% 72.36% 65.43% 47.17%
Average Days of Receivables 62.53 62.29 60.85 62.33
Free Cash Flow per Share 9.33 9.49 9.21 8.12
Free Cash Flow 1,105.00 1,139.10 1,134.30 999.40
Capital Expenditures (507.40) (494.60) (481.40) (470.30)
Piotroski F-Score 6.00 7.00 7.00 7.00
Other line items
Cash ROIC 18.69% 18.56% 18.24% 15.98%
Accounts Receivable Turnover 6.01 6.01 6.17 6.04
Accounts Payable Turnover 19.18 16.67 15.35 16.82
Inventory Turnover 0.00 0.00 0.00 0.00
Average Days of Payables 16.13 20.98 28.48 21.93
Days of Inventory on Hand 0.00 0.00 0.00 0.00
Tax Rate (0.26) (0.26) (0.26) (0.25)
Research and Development Expense of Revenue 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue 26.20% 26.27% 26.57% 25.88%
Share Based Compensation of Revenue 1.43% 1.40% 1.29% 1.24%
Interest Coverage 0.00 0.00 0.00 0.00
Operating CF/Net income 2.33 2.34 2.45 2.23
Depreciation/Fixed assets 0.39 0.38 0.38 0.37
Capex/Depreciation (0.68) (0.67) (0.66) (0.66)
Revenue per Share 54.43 52.35 49.31 48.28
Operating CF per Share 13.62 13.61 13.11 11.94
Capex per Share (4.29) (4.12) (3.91) (3.82)
Capex to Sales 0.08 0.08 0.08 0.08
Net Profit Margin 10.73% 11.12% 10.87% 11.08%

Fold the line items

Columns are period end dates